Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-21-007185
Filing Date
2021-06-30
Accepted
2021-06-30 16:22:02
Documents
1
Period of Report
2021-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3926
  Complete submission text file 0001179110-21-007185.txt   5279
Mailing Address 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063
Business Address
Popovits Kimberly J (Reporting) CIK: 0001333482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 211062184

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations